Polypharmacy in older adults at home: What it is and what to do about it- Implications for home healthcare and hospice

Home Healthcare Nurse

Volumn 30, Issue 8, 2012, Pages 474-485

  Riker, Gretchen I ^a   Setter, Stephen M ^b  

^a UNIVERSITY OF MARYLAND EASTERN SHORE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; DRUG EFFECT; DRUG UTILIZATION; FEMALE; GERIATRIC ASSESSMENT; HOME CARE; HOSPICE CARE; HUMAN; MALE; NEEDS ASSESSMENT; NURSE ATTITUDE; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; POLYPHARMACY; PRESCRIPTION; REVIEW; RISK FACTOR; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; GERIATRIC ASSESSMENT; HOME CARE SERVICES; HOSPICE CARE; HUMANS; MALE; NEEDS ASSESSMENT; NURSE'S ROLE; PATIENT EDUCATION AS TOPIC; POLYPHARMACY; RISK FACTORS; UNITED STATES;

EID: 84866086287     PISSN: 0884741X     EISSN: 15390713     Source Type: Journal    
DOI: 10.1097/NHH.0b013e31826502dd     Document Type: Article

References (44)

1. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. (2012). American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. The Journal of the American Geriatrics Society, 60(4), 616-631.
2. Arias, E. (2011). United states life tables, 2007. National Vital Statistics Reports, 59(9).
3. Avorn, J. (2005). Powerful medicines: The benefits, risks, and costs of prescription drugs. New York, NY: Random House.
4. Barry, P. J., Gallagher, P., Ryan, C., & O'Mahony, D. (2007). START (screening tool to alert doctors to the right treatment): An evidence-based screening tool to detect prescribing omissions in elderly patients. Age and Ageing, 36, 632-638. doi: 10.1093/ageing/afm118
5. Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Bulpitt, C. J. (2008). Treatment of hypertension in patients 80 years of age or older. New England Journal of Medicine, 358(18), 1887-1898. doi: 10.1056/NEJMoa081369; vol 358, no 18
6. Bootman, J. L., Harrison, D. L., & Cox, E. (1997). The health care cost of drug-related morbidity and mortality. Archives of Internal Medicine, 157(18), 2089-2096.
7. Boult, C., & Wieland, G. D. (2010). Comprehensive primary care for older patients with multiple chronic conditions: "Nobody rushes you through." Journal of the American Medical Association, 304(17), 1936-1943.
8. Boyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005). Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. Journal of the American Medical Association, 294(6), 716-724.
9. Brown, A. F., Mangione, C. M., Saliba, D., Sarkisian, C. A., & the California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. (2003). Guidelines for improving care of the older person with diabetes mellitus. Journal of the American Geriatrics Society, 51(5 Suppl.), S265-S280.
10. Budnitz, D. S., Lovegrove, M. C., Shehab, N., & Richards, C. L., (2011). Emergency hospitalizations for adverse drug events in older Americans. New England Journal of Medicine, 365, 2002-2012.
11. Bushardt, R. L., Massey, E. B., Simpson, T. W., Ariail, J. C., & Simpson, K. N. (2008). Polypharmacy: Misleading, but manageable. Clinical Interventions in Aging, 3(2), 383-389.
12. Carlson, J. E. (1996). Perils of polypharmacy: 10 steps to prudent prescribing. Geriatrics, 51(7), 26-30, 35.
13. Chan, M., Nicklason, F., & Vial, J. H. (2001). Adverse drug events as a cause of hospital admission in the elderly. Internal Medicine Journal, 31(4), 199-205.
14. Coleman, E. A., Smith, J. D., Raha, D., & Min, S. J. (2005). Posthospital medication discrepancies: Prevalence and contributing factors. Archives of Internal Medicine, 165(16), 1842-1847.
15. Flora, D. S., Parsons, P. L., & Slattum, P. W. (2012). Managing medications for improved care transitions. Generations, 35(4), 37-42.
16. Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. F., & Bates, D. W. (2003). The incidence and severity of adverse events affecting patients after discharge from the hospital. Annals of Internal Medicine, 138(3), 161-167.
17. Gallagher, P., Ryan, C., Bryne, S., Kennedy, J., & O'Mahony, D. (2008). STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment): Consensus validation. International Journal of Clinical Pharmacology and Therapeutics, 46(2), 72-83.
18. Gnjidic, D., Le Courteur, D. G., Abernethey, D. R., & Hilmer, S. N. (2012). Drug Burden Index and beers criteria: Impact on functional outcomes in older people living in self-care retirement villages. Journal of Clinical pharmacology, 52(2), 258-265.
19. Gurwitz, J. H. (2004). Polypharmacy: A new paradigm for quality drug therapy in the elderly? Archives of Internal Medicine, 164(18), 1957-1959.
20. Hamilton, H., Gallager, P., Ryan, C., Byrne, S., & O'Mahony, D. (2011). Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Archives of Internal Medicine, 171(11), 1013-1019.
21. Hanlon, J. T., Schmader, K. E., Samsa, G. P., Weinberger, M., Uttech, K. M., Lewis, I. K., Feussner, J. R. (1992). A method for assessing drug therapy appropriateness. Journal of Clinical Epidemiology, 45(10), 1045-1051.
22. Hayes, B. D., Klein-Schwartz, W., & Barrueto, F., Jr. (2007). Polypharmacy and the geriatric patient. Clinics Geriatric Medicine, 23(2), 371-390.
23. Lee, R. D. (1998). Polypharmacy: A case report and new protocol for management. Journal of the Board of Family Medicine, 11(2), 140-144.
24. Lee, S. J., & Walter, L. C. (2011). Quality indicators for older adults: Preventing unintended harms. Journal of the American Medical Association, 306(13), 1481-1482.
25. McCloskey, A. (2000). Cost overdose: Growth in drug spending for the elderly, 1992-2010. Washington, DC: Families USA.
26. McLendon, A. N., & Shelton, P. S. (2012). New symptoms in older adults: Disease or drug? Generations, 35(4), 25-30.
27. Montamat, S. C., & Cusack, B. (1992). Overcoming problems with polypharmacy and drug misuse in the elderly. Clinical Geriatric Medicine, 8(1), 143-158.
28. Morley, J. E. (2011). The cholesterol conundrum. Journal of the American Geriatrics Society, 59(10), 1955-1956.
29. Peron, E. P., & Ruby, C. M. (2012). Primer on medication use in older adults for the non-clinician. Generations, 35(4), 12-18.
30. Reimer-Kirkham, S., Grypma, S., Pesut, B., Sharma, S., Sawatzky, R., Cochrane, M., Klassesn, P. (2012). Considering place: Religious, spiritual and cultural plurality in home health, three year study funded by Social Sciences and Humanities Research Council of Canada (2009-2012). Unpublished manuscript.
31. Rochon, P. A., & Gurwitz, J. H. (1995). Drug therapy. Lancet, 346(8966), 32-36.
32. Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G., & Epstein, A. M. (2002). Promotion of prescription prescription drugs to consumers. New England Journal of Medicine, 346(7), 498-505.
33. Rossi, M. I., Young, A., Maher, R., Rodriguez, K. L., Appelt, C. J., Perera, S., .., Hanlon, J. T. (2007). Polypharmacy and health beliefs in older outpatients. American Journal of Geriatric Pharmacotherapy, 5(4), 317-323.
34. Sergi, G., De Rui, M., Sarti, S., & Manzato, E. (2011). Polypharmacy in the elderly: Can Comprehensive Geriatric Assessment reduce inappropriate medication use? Drugs & Aging, 28(7), 509-518.
35. Setter, S. M., Corbett, C. F., Neumiller, J. J., Gates, B. J., Sclar, D. A., & Sonnett, T. E. (2009). Effectiveness of a pharmacists-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care. American Journal of Health-System Pharmacy, 66(22), 2027-2031.
36. Sloan, J. (2012). Medicating elders in the evidence-free zone. Generations, 35(4), 56-61.
37. Steinman, M. A., & Hanlon, J. T. (2010). Managing medications in clinically complex elders. Journal of the American Medical Association, 304(14), 1592-1601.
38. Steinman, M. A., Landefeld, C. S., Rosenthal, G. E., Berthenthal, D., Sen, S., & Kaboli, P. J. (2006). Polypharmacy and prescribing quality in older people. Journal of the American Geriatrics Society, 54(10), 1516-1523.
39. U.S. Department of Health and Human Services. (2011). Improving care transitions. Retrieved from http://www.healthcare.gov/compare/partnership- forpatients/safety/transitions.html.
40. Viktil, K. K., Blix, H. S., Moger, T. A., & Reikvam, A. (2006). Polypharmacy as commonly defined is an indicator of limited value in the assessment of drugrelated problems. British Journal of Clinical Pharmacology, 63(2), 187-195.
41. Vincent, G. K., &Velkoff, V. A. (2010). The next four decades, the older population in the United States: 2010 to 2050. In Current population reports, 25-1138. Washington, DC: U.S. Census Bureau.
42. Wenger, N. S., Shekelle, P. G., & Assessing Care of Vulnerable Elders [ACOVE] Investigators. (2001). Assessing Care of Vulnerable Elders: ACOVE project overview. Annals of Internal Medicine, 135(8 Pt. 2), 642-646.
43. Yang, J. C., Tomlinson, G., & Naglie, G. (2001). Medication lists for elderly patients: Clinic-derived versus in-home inspection and interview. Journal of General Internal Medicine, 16(2), 112-115.
44. Ziere, G., Dieleman, J. P., Hofman, A., Pols, H. A., van der Cammen, T. J., & Stricker, B. H. (2006). Polypharmacy and falls in the middle age and elderly population. British Journal of Clinical Pharmacology, 61(2), 218-223.